Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies Week 2022 | Looking forward to Advanced Therapies Week 2022

Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine, Washington, D.C., shares her excitement towards meeting colleagues and learning about the latest scientific advances at the Advanced Therapies Week 2022, in particular in in vivo gene editing and in vivo chimeric antigen receptor (CAR) T-cells. This interview took place at Advanced Therapies Week 2022.


Janet Lynch Lambert is the CEO of Alliance for Regenerative Medicine.